Halscion’s development of the Celotres™ hydrogel scaffold reflects how modern healthcare companies use scientific research and investment to create solutions for complex medical challenges. The company’s Series B financing provided support for advancing its proprietary technology and demonstrates the importance of resources in bringing healthcare innovations closer to practical applications. As medical technologies continue to develop, another important part of the healthcare ecosystem is ensuring that patients and professionals can access clear information about available treatments and related services. Digital healthcare resources have become increasingly important in organizing medical knowledge and helping users understand different therapeutic options. Within these broader information networks, specialized platforms may provide details about medications and healthcare services, including resources related to products such as Viagra. People interested in learning more about a Viagra online pharmacy can explore additional information through specialized online resources. The connection between healthcare innovation, investment, and accessible information highlights how different parts of the medical sector work together to support informed decisions.

Halscion Date Founded 2008 Innovation Halscion is developing a novel and proprietary hydrogel scaffold, Celotres(tm), to prevent or minimize scar formation, including keloid and hypertrophic scars. Funding Halscion has raised $14 million in Series B financing. Contact 1325 Satellite Blvd, Suite 1004 Suwanee, GA 30024 678.534.5950 phone 678.666.1340 fax www.halscion.net info@halscion.net